Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | HTR5A | P47898 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.33 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.33 |
| ▸ | S1PR4 | O95977 | 3/20 | 0.31 |
| ▸ | S1PR5 | Q9H228 | 3/20 | 0.31 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11030653 | 0.94 | HTR2B (0.45) | HTR2BHTR5AALOX5MAPK9MAPK10 | |
| SCHEMBL30606988 | 0.94 | HTR2B (0.45) | HTR2BHTR5AALOX5MAPK9MAPK10 | |
| SCHEMBL11941212 | 0.92 | HTR2B (0.44) | HTR2BHTR5AALOX5MAPK9MAPK10 | |
| SCHEMBL11941215 | 0.91 | HTR2B (0.40) | HTR2BHTR5AALOX5MAPK9MAPK10 | |
| SCHEMBL20909407 | 0.90 | ALOX5 (0.38) | ALOX5PRKDCMAPT | |
| SCHEMBL11941211 | 0.89 | HTR2B (0.40) | HTR2BHTR5AALOX5MAPK9MAPK10 | |
| SCHEMBL11941207 | 0.89 | HTR2B (0.44) | HTR2BHTR5AALOX5MAPK9MAPK10 | |
| SCHEMBL21702871 | 0.88 | ALOX5 (0.43) | HTR2BHTR5AALOX5MAPK9MAPK10 | |
| SCHEMBL11941218 | 0.87 | HTR2B (0.44) | HTR2BHTR5AALOX5MAPK9MAPK10 | |
| SCHEMBL26179822 | 0.86 | HTR2B (0.39) | HTR2BHTR5AALOX5MAPK9MAPK10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11201290-B2 | Tetraphenylene anthracene compounds | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2021-12-14 | — | — | US | disclosed |
| US-20190115541-A1 | TETRAPHENYLENE ANTHRACENE COMPOUNDS | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2019-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190115541-A1 | TETRAPHENYLENE ANTHRACENE COMPOUNDS | TRPA1, SLC29A2, XPOT | HTR2B 3863/4885HTR5A 3956/4885ALOX5 2952/4885 |
| US-11201290-B2 | Tetraphenylene anthracene compounds | TRPA1, SLC29A2, XPOT | HTR2B 3863/4885HTR5A 3956/4885ALOX5 2952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.